Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

Voyager Cheers End Of Sanofi Partnership In Parkinson's; Investors Less Confident

Nov 01 2017

• By Mandy Jackson

DNA detail background with selective focus

Related Content

Biotech IPO Window Closed In November As Returns And Prices Plunged

Dec 03 2015

Genzyme commits $100m upfront for Voyager's gene therapy expertise in CNS

Feb 12 2015

Third Rock funds gene therapy startup Voyager with $45m

Feb 13 2014

Voyager's Parkinson's Gene Therapy Poised For Pivotal Trial Exploration

Sep 06 2017

Sanofi-Backed Voyager Therapeutics Hails Gene Therapy's Arrival

Aug 22 2017

Related Companies

Voyager Therapeutics, Inc

Sanofi

Additional Topics

Deals Business Strategies Commercial Neurology BioPharmaceutical

More from Deals

More from Business

Twitter feed RSS feed RSS feed

About UsOpens in new window
Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us
Customer Service
Subscribe
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window